Literature DB >> 14644971

Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study.

Peter Brindle1, Jonathan Emberson, Fiona Lampe, Mary Walker, Peter Whincup, Tom Fahey, Shah Ebrahim.   

Abstract

OBJECTIVE: To establish the predictive accuracy of the Framingham risk score for coronary heart disease in a representative British population.
DESIGN: Prospective cohort study.
SETTING: 24 towns in the United Kingdom. PARTICIPANTS: 6643 British men aged 40-59 years and free from cardiovascular disease at entry into the British regional heart study. MAIN OUTCOME MEASURES: Comparison of observed 10 year coronary heart disease mortality and event rates with predicted rates for each individual, using the relevant Framingham risk equation.
RESULTS: Of 6643 men, 2.8% (95% confidence interval 2.4% to 3.2%) died from coronary heart disease compared with 4.1% predicted (relative overestimation 47%, P < 0.0001). A fatal or non-fatal coronary heart disease event occurred in 10.2% (9.5% to 10.9%) of the men compared with 16.0% predicted (relative overestimation 57%, P < 0.0001). These relative degrees of overestimation were similar at all levels of coronary heart disease risk, so that overestimation of absolute risk was greatest for those at highest risk. A simple adjustment provided an improved level of accuracy. In a "high risk score" approach, most cases occur in the low risk group. In this case, 84% of the deaths from coronary heart disease and non-fatal events occurred in the 93% of men classified at low risk (< 30% in 10 years) by the Framingham score.
CONCLUSION: Guidelines for the primary prevention of coronary heart disease advocate offering preventive measures to individuals at high risk. Currently recommended risk scoring methods derived from the Framingham study significantly overestimate the absolute coronary risk assigned to individuals in the United Kingdom.

Entities:  

Mesh:

Year:  2003        PMID: 14644971      PMCID: PMC286248          DOI: 10.1136/bmj.327.7426.1267

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  29 in total

1.  Updated New Zealand cardiovascular disease risk-benefit prediction guide.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

3.  Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors:  J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

4.  Primary prevention of coronary heart disease.

Authors:  Peter Brindle; Tom Fahey
Journal:  BMJ       Date:  2002-07-13

5.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

6.  An updated coronary risk profile. A statement for health professionals.

Authors:  K M Anderson; P W Wilson; P M Odell; W B Kannel
Journal:  Circulation       Date:  1991-01       Impact factor: 29.690

7.  Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators.

Authors:  F Gueyffier; F Boutitie; J P Boissel; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; M Perry; R Prineas; E Schron
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

8.  A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials.

Authors:  S J Pocock; V McCormack; F Gueyffier; F Boutitie; R H Fagard; J P Boissel
Journal:  BMJ       Date:  2001-07-14

9.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

10.  Cardiovascular disease risk profiles.

Authors:  K M Anderson; P M Odell; P W Wilson; W B Kannel
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

View more
  130 in total

1.  Risk factor scoring for coronary heart disease.

Authors:  Hans-Werner Hense
Journal:  BMJ       Date:  2003-11-29

Review 2.  Cardiology.

Authors:  Tom Fahey; Knut Schroeder
Journal:  Br J Gen Pract       Date:  2004-09       Impact factor: 5.386

Review 3.  Chronic Inflammatory Diseases and Endothelial Dysfunction.

Authors:  Xavier Castellon; Vera Bogdanova
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

4.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

5.  Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA study.

Authors:  Pierre-Jean Touboul; Rafael Hernández-Hernández; Serdar Küçükoğlu; Kam-Sang Woo; Eric Vicaut; Julien Labreuche; Chris Migom; Honorio Silva; Raul Vinueza
Journal:  Int J Cardiovasc Imaging       Date:  2006-12-21       Impact factor: 2.357

6.  The value of risk scores.

Authors:  J S Jürgensen
Journal:  Heart       Date:  2006-06-06       Impact factor: 5.994

7.  Cardiovascular risk estimation: important but may be inaccurate.

Authors:  Vishnu Madhok; Tom Fahey
Journal:  BMJ       Date:  2006-05-31

Review 8.  Role of noninvasive imaging in asymptomatic high-risk patients.

Authors:  Leslee J Shaw; Allen Taylor; Paolo Raggi; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

9.  Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study.

Authors:  D A Lawlor; G Davey Smith; S Ebrahim
Journal:  Diabetologia       Date:  2005-12-23       Impact factor: 10.122

10.  Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study.

Authors:  Linn Getz; Johann A Sigurdsson; Irene Hetlevik; Anna Luise Kirkengen; Solfrid Romundstad; Jostein Holmen
Journal:  BMJ       Date:  2005-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.